p53 is balancing development, differentiation and de-differentiation to assure cancer prevention

被引:125
作者
Molchadsky, Alina [1 ]
Rivlin, Noa [1 ]
Brosh, Ran [1 ]
Rotter, Varda [1 ]
Sarig, Rachel [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
基金
以色列科学基金会;
关键词
WILD-TYPE P53; GENE INDUCES DIFFERENTIATION; TUMOR-SUPPRESSOR PROTEIN; NEURAL STEM-CELLS; EMBRYONIC LETHALITY; SELF-RENEWAL; OSTEOBLAST DIFFERENTIATION; ADIPOCYTE DIFFERENTIATION; TERMINAL DIFFERENTIATION; P53-DEPENDENT APOPTOSIS;
D O I
10.1093/carcin/bgq101
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many of the roles played by the tumor suppressor p53 in restraining cancer initiation and progression are well established. These include the ability of p53 to induce cell-cycle arrest, DNA repair, senescence and apoptosis. In addition, during the 30 years of p53 research, numerous studies have implicated p53 in the regulation of differentiation and developmental pathways. Here, we summarize the data on these relatively less-characterized functions of p53, including its involvement in embryogenesis and various differentiation programs, as well as its function in restraining de-differentiation of mature somatic cells. Besides the well-known functions of p53 as a cell-cycle regulator and a mediator of apoptosis, both coincide with differentiation processes, p53 was shown to exert its effects on various differentiation programs via direct regulation of specific key factors controlling these programs. The complex regulation by p53, which acts to suppress or to induce differentiation, is mainly the result of the specific cell type and fate. We argue that regulation of differentiation is pivotal for the tumor-suppressive activity of p53, which act to maintain the proper cellular state, preventing improper maturation or reprogramming. This conclusion is further supporting the notion that aberrant differentiation is associated with malignant transformation.
引用
收藏
页码:1501 / 1508
页数:8
相关论文
共 146 条
[41]   Energy deregulation: Licensing tumors to grow [J].
Garber, K .
SCIENCE, 2006, 312 (5777) :1158-1159
[42]   Developmental origin of fat: Tracking obesity to its source [J].
Gesta, Stephane ;
Tseng, Yu-Hua ;
Kahn, C. Ronald .
CELL, 2007, 131 (02) :242-256
[43]   Oct-3/4 is a dose-dependent oncogenic fate determinant [J].
Gidekel, S ;
Pizov, G ;
Bergman, Y ;
Pikarsky, E .
CANCER CELL, 2003, 4 (05) :361-370
[44]   Transgenic mouse model for studying the transcriptional activity of the p53 protein: Age- and tissue-dependent changes in radiation-induced activation during embryogenesis [J].
Gottlieb, E ;
Haffner, R ;
King, A ;
Asher, G ;
Gruss, P ;
Lonai, P ;
Oren, M .
EMBO JOURNAL, 1997, 16 (06) :1381-1390
[45]   Cancer stem cells: mirage or reality? [J].
Gupta, Piyush B. ;
Chaffer, Christine L. ;
Weinberg, Robert A. .
NATURE MEDICINE, 2009, 15 (09) :1010-1012
[46]   P53 GENE IS UP-REGULATED DURING SKELETAL-MUSCLE CELL-DIFFERENTIATION [J].
HALEVY, O .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (02) :714-719
[47]  
Hallenborg P, 2009, EXPERT OPIN THER TAR, V13, P235, DOI [10.1517/14712590802680141, 10.1517/14712590802680141 ]
[48]   Direct cell reprogramming is a stochastic process amenable to acceleration [J].
Hanna, Jacob ;
Saha, Krishanu ;
Pando, Bernardo ;
van Zon, Jeroen ;
Lengner, Christopher J. ;
Creyghton, Menno P. ;
van Oudenaarden, Alexander ;
Jaenisch, Rudolf .
NATURE, 2009, 462 (7273) :595-U63
[49]   Mdm2 promotes the rapid degradation of p53 [J].
Haupt, Y ;
Maya, R ;
Kazaz, A ;
Oren, M .
NATURE, 1997, 387 (6630) :296-299
[50]   Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues [J].
Hochedlinger, K ;
Yamada, Y ;
Beard, C ;
Jaenisch, R .
CELL, 2005, 121 (03) :465-477